Pharmacophore-based virtual screening, molecular docking, and molecular dynamics investigation for the identification of novel, marine aromatase inhibitors. [PDF]
Kotb MA, Abdelmawgood IA, Ibrahim IM.
europepmc +1 more source
Identification of novel PAD2 inhibitors using pharmacophore-based virtual screening, molecular docking, and MD simulation studies. [PDF]
Jha P, Rajoria P, Poonia P, Chopra M.
europepmc +1 more source
Development of Multi-Target Pharmacophore-Based Virtual Screening Agent Against COVID-19
Ibrahim N, Gouda A, El-Sherief H.
europepmc +1 more source
Non-Extensive Fragmentation of Natural Products and Pharmacophore-Based Virtual Screening as a Practical Approach to Identify Novel Promising Chemical Scaffolds. [PDF]
Vásquez AF +3 more
europepmc +1 more source
Pharmacophore-based virtual screening and <i>in silico</i> investigations of small molecule library for discovery of human hepatic ketohexokinase inhibitors for the treatment of fructose metabolic disorders. [PDF]
Elsaman T +11 more
europepmc +1 more source
Quinazoline-2,4(1H,3H)-dione derivatives as new class of CB1 Agonists: A pharmacophore-based virtual screening workflow and drug discovery. [PDF]
El Aissouq A +6 more
europepmc +1 more source
Pharmacophore-based virtual screening of commercial databases against β-secretase 1 for drug development against Alzheimer's disease. [PDF]
Han X, Guo K.
europepmc +1 more source
Using Chou's 5-steps rule to study pharmacophore-based virtual screening of SARS-CoV-2 Mpro inhibitors. [PDF]
Pundir H +6 more
europepmc +1 more source
Insilico exploration C. koseri ATP synthase inhibitors by pharmacophore-based virtual screening, molecular docking and MD simulation. [PDF]
Alanzi AR, A Z A, Alhazzani K.
europepmc +1 more source
Integration of pharmacophore-based virtual screening, molecular docking, ADMET analysis, and MD simulation for targeting EGFR: A comprehensive drug discovery study using commercial databases. [PDF]
Alanzi AR +4 more
europepmc +1 more source

